PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDER

PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDER.

路 Analyze the influence of patient factors on pharmacokinetic and pharmacodynamic processes

路 Analyze the impact of changes in pharmacokinetic and pharmacodynamic processes on patient drug therapies

Save your time - order a paper!

Get your paper written from scratch within the tight deadline. Our service is a reliable solution to all your troubles. Place an order on any task and we will take care of it. You won鈥檛 have to worry about the quality and deadlines

Order Paper Now

路 Evaluate drug therapy plans for cardiovascular disorders

Cardiovascular / Respiratory Systems

CASE STUDY Assignment

Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following:

鈥 Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun

鈥 Aspirin 81 mg daily

鈥 Metformin 1000 mg po bid

鈥 Glyburide 10 mg bid

鈥 Atenolol 100 mg po daily

鈥 Motrin 200 mg 1鈥3 tablets every 6 hours as needed for pain

To Prepare

路 Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.

路 Review the case study assigned by your Instructor for this Assignment.

路 Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.

路 Reflect on how the factor you selected might influence the patient鈥檚 pharmacokinetic and pharmacodynamic processes.

路 Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient鈥檚 recommended drug therapy.

路 Think about how you might improve the patient鈥檚 drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.

Write聽a 2- to 3-page paper that addresses the following:

路 Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study assigned above.

路 Describe how changes in the processes might impact the patient鈥檚 recommended drug therapy. Be specific and provide examples.

路 Explain how you might improve the patient鈥檚 drug therapy plan and explain why you would make these recommended improvements.

Resources for reference

Rosenthal, L. D., & Burchum, J. R. (2018).聽Lehne鈥檚 pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.

路 Chapter 34, 鈥淩eview of Hemodynamics鈥 (pp. 335鈥340)

路 Chapter 35, 鈥淒iuretics鈥 (pp. 341鈥349)

路 Chapter 36, 鈥淒rugs Acting on the Renin-Angiotensin-Aldosterone System鈥 (pp. 351鈥362)

路 Chapter 37, 鈥淐alcium Channel Blockers鈥 (pp. 363鈥369)

路 Chapter 38, 鈥淰asodilators鈥 (pp. 371鈥373)

路 Chapter 39, 鈥淒rugs for Hypertension鈥 (pp. 375鈥388)

路 Chapter 40, 鈥淒rugs for Heart Failure鈥 (pp. 389鈥402)

路 Chapter 41, 鈥淎ntidysrhythmic Drugs鈥 (pp. 403鈥418)

路 Chapter 42, 鈥淧rophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels鈥 (pp. 419鈥439)

路 Chapter 43, 鈥淒rugs for Angina Pectoris鈥 (pp. 441鈥450)

路 Chapter 44, 鈥淎nticoagulant and Antiplatelet Drugs鈥 (pp. 451鈥472)

Include 3-4 references

PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDER

 
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"